BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34588605)

  • 21. A novel anti-human HB-EGF monoclonal antibody with multiple antitumor mechanisms against ovarian cancer cells.
    Miyamoto S; Iwamoto R; Furuya A; Takahashi K; Sasaki Y; Ando H; Yotsumoto F; Yoneda T; Hamaoka M; Yagi H; Murakami T; Hori S; Shitara K; Mekada E
    Clin Cancer Res; 2011 Nov; 17(21):6733-41. PubMed ID: 21918176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ca2+ signalling by endothelin receptors in rat and human cultured airway smooth muscle cells.
    Maxwell MJ; Goldie RG; Henry PJ
    Br J Pharmacol; 1998 Dec; 125(8):1768-78. PubMed ID: 9886769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H
    Kato Y; Ohishi T; Takei J; Nakamura T; Sano M; Asano T; Sayama Y; Hosono H; Kawada M; Kaneko MK
    Monoclon Antib Immunodiagn Immunother; 2020 Aug; 39(4):123-128. PubMed ID: 32552424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvianolic Acid A, as a Novel ETA Receptor Antagonist, Shows Inhibitory Effects on Tumor in Vitro.
    Zhang Q; Wang S; Yu Y; Sun S; Zhang Y; Zhang Y; Yang W; Li S; Qiao Y
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reassessment of endothelin receptor A expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-8.
    Lupp A; Mann A; Heeb A; Kaemmerer D; Sänger J; Evert M; Evert K; Mawrin C; Schulz S
    Peptides; 2015 Apr; 66():19-25. PubMed ID: 25708416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist.
    Nishikibe M; Ohta H; Okada M; Ishikawa K; Hayama T; Fukuroda T; Noguchi K; Saito M; Kanoh T; Ozaki S; Kamei T; Hara K; William D; Kivlighn S; Krause S; Gabel R; Zingaro G; Nolan N; O'Brien J; Clayton F; Lynch J; Pettibone D; Siegl P
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1262-70. PubMed ID: 10336515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells.
    Soldano S; Paolino S; Pizzorni C; Trombetta AC; Montagna P; Brizzolara R; Corallo C; Giordano N; Sulli A; Cutolo M
    Clin Exp Rheumatol; 2017; 35(3):484-493. PubMed ID: 28134077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Antihuman Epidermal Growth Factor Receptor 2 Monoclonal Antibody (H
    Kato Y; Ohishi T; Takei J; Nakamura T; Kawada M; Kaneko MK
    Monoclon Antib Immunodiagn Immunother; 2020 Aug; 39(4):135-139. PubMed ID: 32644843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Antibodies Targeting MUC1-C Showed Anti-Metastasis and Growth-Inhibitory Effects on Human Breast Cancer Cells.
    Kim MJ; Choi JR; Tae N; Wi TM; Kim KM; Kim DH; Lee ES
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of Dual ETA/ETB Receptor Antagonists from Traditional Chinese Herbs through in Silico and in Vitro Screening.
    Wang X; Zhang Y; Liu Q; Ai Z; Zhang Y; Xiang Y; Qiao Y
    Int J Mol Sci; 2016 Mar; 17(3):389. PubMed ID: 26999111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of bFGF monoclonal antibody and its inhibition of metastasis in Lewis lung carcinoma.
    Yang Y; Luo Z; Qin Y; Zhou Y; Gong L; Huang J; Wang H
    Mol Med Rep; 2017 Oct; 16(4):4015-4021. PubMed ID: 28765892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Exerted Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor.
    Tanaka T; Ohishi T; Saito M; Suzuki H; Kaneko MK; Kawada M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2022 Jun; 41(3):142-149. PubMed ID: 35666554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Monoclonal Antibody Antagonizing Endothelin Receptor A for Pulmonary Arterial Hypertension.
    Zhang C; Wang X; Zhang H; Yao C; Pan H; Guo Y; Fan K; Jing S
    J Pharmacol Exp Ther; 2019 Jul; 370(1):54-61. PubMed ID: 30992315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methods for assessing endothelin ETA-receptor antagonists in preclinical studies.
    Okada M; Siegl PK; Nishikibe M
    Methods Find Exp Clin Pharmacol; 2002; 24(6):361-70. PubMed ID: 12224443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation and desensitization of human endothelin A and B receptors. Evidence for G protein-coupled receptor kinase specificity.
    Freedman NJ; Ament AS; Oppermann M; Stoffel RH; Exum ST; Lefkowitz RJ
    J Biol Chem; 1997 Jul; 272(28):17734-43. PubMed ID: 9211925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.
    Douthwaite JA; Sridharan S; Huntington C; Hammersley J; Marwood R; Hakulinen JK; Ek M; Sjögren T; Rider D; Privezentzev C; Seaman JC; Cariuk P; Knights V; Young J; Wilkinson T; Sleeman M; Finch DK; Lowe DC; Vaughan TJ
    MAbs; 2015; 7(1):152-66. PubMed ID: 25484051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Fully Human Agonistic Single Chain Fragment Variable Antibody Targeting Death Receptor 5 with Potent Antitumor Activity In Vitro and In Vivo.
    Lei G; Xu M; Xu Z; Gu L; Lu C; Bai Z; Wang Y; Zhang Y; Hu H; Jiang Y; Zhao W; Tan S
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28953230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelin-1 decreases [Ca2+]i via Na+/Ca2+ exchanger in CHO cells stably expressing endothelin ETA receptor.
    Horinouchi T; Nishimoto A; Nishiya T; Lu L; Kajita E; Miwa S
    Eur J Pharmacol; 2007 Jul; 566(1-3):28-33. PubMed ID: 17445794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of endothelin-1 and its receptors, ET
    Mikhail M; Vachon PH; D'Orléans-Juste P; Jacques D; Bkaily G
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1298-1305. PubMed ID: 28732172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distortion of K
    Angus JA; Hughes RJA; Wright CE
    Pharmacol Res Perspect; 2017 Dec; 5(6):. PubMed ID: 29226623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.